CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($) $ in Thousands	Total	Common Stock Issued	Additional Paid-in Capital	Treasury Stock	Accumulated Deficit
Balance (in shares) at Dec. 31, 2019		112,703,926		1,885,277
Balance, beginning of period at Dec. 31, 2019	$ 34,398	$ 113	$ 147,231	$ (10,806)	$ (102,140)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	1,915		1,915
Exercise of stock options	298		(1,214)	$ 1,512
Exercise of stock options (in shares)				(170,300)
Restricted stock canceled/forfeited	0		1,746	$ (1,746)
Restricted stock canceled/forfeited (in shares)				242,998
Shares repurchased for tax withholding (in shares)				205,091
Shares repurchased for tax withholding	(1,451)		87	$ (1,538)
Net loss	(4,821)				(4,821)
Balance (in shares) at Mar. 31, 2020		112,703,926		2,163,066
Balance, end of period at Mar. 31, 2020	30,339	$ 113	149,765	$ (12,578)	(106,961)
Balance (in shares) at Dec. 31, 2020		112,703,926		1,773,683
Balance, beginning of period at Dec. 31, 2020	(150)	$ 113	158,610	$ (7,449)	(151,424)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Deemed dividends	(462)		(462)
Share-based compensation expense	3,244		3,244
Exercise of stock options	$ 915		(1,364)	$ 2,279
Exercise of stock options (in shares)	(352,623)			(310,813)
Issuance of restricted stock	$ 0		(3,596)	$ 3,596
Issuance of restricted stock (in shares)				(742,001)
Restricted stock canceled/forfeited	0		301	$ (301)
Restricted stock canceled/forfeited (in shares)				35,589
Shares repurchased for tax withholding (in shares)				326,839
Shares repurchased for tax withholding	(3,216)			$ (3,216)
Net loss	(8,382)				(8,382)
Balance (in shares) at Mar. 31, 2021		112,703,926		1,083,297
Balance, end of period at Mar. 31, 2021	$ (8,051)	$ 113	$ 156,733	$ (5,091)	$ (159,806)